Ultragenyx Pharmaceutical (RARE) Net Equity Issued and Repurchased (2013 - 2022)
Ultragenyx Pharmaceutical (RARE) reported Net Equity Issued and Repurchased of $6 million for FY2025, down 45.5% from $11 million in FY2024.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Net Equity Issued and Repurchased (2013 - 2022) Analysis & Trends
Dating back to FY2012, Ultragenyx Pharmaceutical's Net Equity Issued and Repurchased record includes 14 years.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -57.6% (FY2020 to FY2025).
- The FY2025 figure ranks as the lowest annual Net Equity Issued and Repurchased since FY2013.
- According to Business Quant data, Net Equity Issued and Repurchased came in at $11 million in FY2024 (+37.5%), $8 million in FY2023 (-26.0%), $10.81 million in FY2022 (-73.0%) and $40.1 million in FY2021 (-90.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 5.98 Mn |
| Mar 31, 2022 | 1.76 Mn |
| Dec 31, 2021 | 6.92 Mn |
| Sep 30, 2021 | 7.67 Mn |
| Jun 30, 2021 | 12.74 Mn |
| Mar 31, 2021 | 12.76 Mn |
| Dec 31, 2020 | 400.51 Mn |
| Sep 30, 2020 | 19.19 Mn |
| Jun 30, 2020 | 15.48 Mn |
| Mar 31, 2020 | 380,000.00 |
| Mar 31, 2019 | 330.42 Mn |
| Mar 31, 2018 | 270.97 Mn |
| Dec 31, 2017 | 5.04 Mn |
| Sep 30, 2017 | 1.33 Mn |
| Jun 30, 2017 | 1.50 Mn |
| Mar 31, 2017 | 1.38 Mn |
| Dec 31, 2016 | 24.99 Mn |
| Sep 30, 2016 | 26.07 Mn |
API Access
Ultragenyx Pharmaceutical Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();